Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • August 2019 •
  • 102 pages •
  • Report ID: 5808063 •
  • Format: PDF
The global allergy immunotherapies market was worth US$ 1.6 Billion in 2018. Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth. Looking forward, the analyst expects the market to reach a value of US$ 2.4 Billion by 2024, registering a CAGR of around 7% during 2019-2024.

Report Coverage:
Historical, Current and Future Market Trends

Market Breakup by Treatment Type:
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

Market Breakup by Allergy Type:
Allergic Rhinitis
Asthma
Food Allergy
Venom Allergy
Others

Market Breakup by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market Breakup by Region:
Europe
North America
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.

Key Questions Answered in This Report:
How has the global allergy immunotherapies market performed so far and how will it perform in the coming years?
What are the key regional markets in the global allergy immunotherapies industry?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the allergy type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global allergy immunotherapies industry?
What are the key driving factors and challenges in the global allergy immunotherapies industry?
What is the structure of the global allergy immunotherapies industry and who are the key players?
What is the degree of competition in the global allergy immunotherapies industry?
What are the profit margins in the global allergy immunotherapies industry?